Shenzhen Hepalink Pharmaceutical is a pharmaceutical company based in Shenzhen, China, that makes heparin products derived from porcine sources. It produces heparin sodium active pharmaceutical ingredient and finished heparin injections, serving pharmaceutical manufacturers and healthcare providers in China and in export markets. The company also works in other areas of pharmaceutical manufacturing and distribution, supplying hospitals and medical customers with treatments built around its core heparin business.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 9989, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #960 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendFair
53/100
Mixed trend against its averages.
See the numbers →
Above 200-day average-12.5%
From 52-week high-28.2%
MomentumWeak
45/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-7.9%
6-month return-16.5%
12-month, skipping last month-21.2%
Stability (higher is calmer)Strong
81/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)30.4%
Worst drawdown, 1 year (smaller is calmer)-31.8%
LiquidityFair
67/100
Moderate trading activity.
See the numbers →
Avg daily value traded2.48M HKD
Zero-volume days1.7%
IncomeWeak
33/100
Dividend is small or irregular.
See the numbers →
Dividend yield4.2%
Years with dividends4
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 3.740 – 5.554Daily closes, split-adjusted
Signals
50-day average4.142
200-day average4.525
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.131
Technical summary
Daily
Bearish
4 bullish · 4 neutral · 8 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
3.90
Bullish
EMA 10
3.93
Bullish
SMA 20
3.90
Bullish
EMA 20
3.95
Bullish
SMA 50
4.14
Bearish
EMA 50
4.06
Bearish
SMA 100
4.14
Bearish
EMA 100
4.21
Bearish
SMA 200
4.53
Bearish
EMA 200
4.42
Bearish
Oscillators (daily)
RSI (14)
48.81
Neutral
MACD (12, 26)
-0.05
Bearish
Momentum (12)
-2.34
Bearish
Stochastic %K (14)
66.67
Neutral
Williams %R (14)
-33.33
Neutral
CCI (20)
58.93
Neutral
Pivot points (classic, last session)
S3
3.86
S2
3.89
S1
3.92
Pivot
3.95
R1
3.99
R2
4.02
R3
4.05
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.17 HKD
Yield on today's price
4.19%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
27 May 2026
0.1660
26 May 2025
0.2717
24 May 2023
0.1122
14 Jun 2022
0.0411
28 May 2021
0.1800
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
